CAVITARY PULMONARY INFARCT IN IMMUNOCOMPROMISED HOSTS

Citation
Ti. Morgenthaler et al., CAVITARY PULMONARY INFARCT IN IMMUNOCOMPROMISED HOSTS, Mayo Clinic proceedings, 70(1), 1995, pp. 66-68
Citations number
20
Categorie Soggetti
Medicine, General & Internal
Journal title
ISSN journal
00256196
Volume
70
Issue
1
Year of publication
1995
Pages
66 - 68
Database
ISI
SICI code
0025-6196(1995)70:1<66:CPIIIH>2.0.ZU;2-6
Abstract
Pulmonary disease in immunocompromised patients is common, but cavitar y lung disease is less common and is usually associated with a fungal or mycobacterial infection, Pulmonary embolism is a noninfectious caus e of a cavitary pulmonary process, Pulmonary embolism causes infarctio n in fewer than 15% of cases, and only about 5% of infarctions cavitat e, Herein we describe two cases of cavitary infarcts in immunocompromi sed patients and review the clinical aspects of pulmonary infarcts and cavitation. Cavitary pulmonary infarction has been reported only rare ly in immunocompromised patients, It is a dangerous but treatable pulm onary disease that must be considered in the differential diagnosis of immunocompromised patients with lung disease,